Amundi, Europe's largest asset manager, increased its stake in Microstrategy (MSTR) by 44% in the third quarter to 1,903,725 shares valued at $291.4 million as of Sept. 30, according to a Form 13F filed Nov. 6. The Paris-based firm held 1,324,053 shares worth $115.1 million on June 30, adding 579,672 shares over the quarter.

MSTR shares closed at $153.09 on Sept. 30 but traded near $126 on the Monday after the filing, a drop of roughly 18% that would reduce the value of Amundi's disclosed position to near $239 million at current prices. The 13F is a snapshot that folds positions across 17 other managers in Amundi's group, potentially including client and fund holdings rather than a single proprietary position.

Microstrategy itself continued accumulating bitcoin. The company purchased 1,036 bitcoin last week for $81.9 million at an average of $79,012, bringing its treasury to 850,364 BTC acquired for $64.16 billion at an average of $75,456. That cost basis now sits above the current spot price, leaving the holdings underwater on paper.

Barclays also expanded bitcoin exposure in Q3. Its 13F shows the bank held 3,942,900 shares of BlackRock's iShares Bitcoin Trust (IBIT) worth $186.7 million at Sept. 30, up 48% from 2,658,147 shares three months prior. Like the Amundi line, the filing covers client and managed positions alongside proprietary holdings.

Both filings suggest European institutional managers continued adding bitcoin proxies during Q3 as the spot market cooled into fall. Bitcoin has since slipped into the mid-$70,000s, and Microstrategy stock has tracked lower with it. Amundi's next 13F will show whether the firm held, trimmed, or continued adding through October's decline.